Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Thursday that its first quarter 2019 revenues rose 7 percent over the first quarter of 2018.

For the three months ended March 31, 2019, the San Carlos, California-based molecular diagnostics firm reported revenues of $66.8 million compared to Q1 2018 revenues of $62.3 million. It beat the average analyst revenue estimate of $65.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
10

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.